M-CSF attenuates severity of chronic GVHD after unrelated BMT

F. Kimura, K. Sato, H. Akiyama, H. Sao, Shinichiro Okamoto, N. Kobayashi, M. Hara, K. Kawa, K. Motoyoshi

Research output: Contribution to journalArticle

4 Citations (Scopus)


To study the effects of M-CSF administration on long-term outcomes of unrelated BMT, we retrospectively analyzed data from patients transplanted through the Japan Marrow Donor Program. We obtained data from 54 patients who received M-CSF just after BMT and 500 patients who did not receive M-CSF or G-CSF acted as controls. There were no significant differences between the two cohorts with respect to OS, acute GVHD or relapse. Although the incidence of chronic GVHD was comparable between the two groups, extensive chronic GVHD was observed significantly less often in the M-CSF cohort than in the control group. Multivariate analysis identified M-CSF as a significant factor for attenuating extensive chronic GVHD (relative risk: 0.73; 95% confidence interval: 0.55-0.94; P=0.012). We also found the same results in matched-pair analysis. Our observation suggests the potential for clinical use of M-CSF to dampen severe chronic GVHD.

Original languageEnglish
Pages (from-to)426-429
Number of pages4
JournalBone Marrow Transplantation
Issue number3
Publication statusPublished - 2012 Jan 1


  • chronic GVHD
  • M-CSF
  • unrelated BMT

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'M-CSF attenuates severity of chronic GVHD after unrelated BMT'. Together they form a unique fingerprint.

  • Cite this

    Kimura, F., Sato, K., Akiyama, H., Sao, H., Okamoto, S., Kobayashi, N., Hara, M., Kawa, K., & Motoyoshi, K. (2012). M-CSF attenuates severity of chronic GVHD after unrelated BMT. Bone Marrow Transplantation, 47(3), 426-429. https://doi.org/10.1038/bmt.2011.90